Medical Devices Late Stage Investors & VC Firms

489 firms in this list, with a median first check of $1.1M. 105 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
PB PBM Capital PBJRJPSG6 people	88🔒	Charlottesville	US	Seed–Late Stage	—	+ Add to CRM
PE Percipient Capital EFJGJB3 people	88🔒	London	GB	Seed–Late Stage	$1.3M – $6.3M	+ Add to CRM
WA Waterman Ventures PRMKWV3 people	88🔒	Utrecht	NL	Seed–Late Stage	—	+ Add to CRM
BI BioFrontier Partners, Inc. YOHSMFHS11 people	88🔒	Tokyo	JP	Series A–Late Stage	$500K – $3M	+ Add to CRM
FL Flying L Partners WLACMLRL5 people	88🔒	—		Late Stage	—	+ Add to CRM
ME Med-Fine Capital KUJZAYAL8 people · Follows rounds	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
NE NewMargin Ventures YHCTHHHK5 people	88🔒	Shanghai	CN	Pre-Seed–Late Stage	$425K – $200M	+ Add to CRM
OR Origin Partners MYMEEJST5 people	88🔒	Hillsborough	US	Seed–Late Stage	$3M – $5M	+ Add to CRM
SE Seido Capital CPOBTRPE4 people · Leads rounds	88🔒	Brussels	BE	Pre-Seed–Late Stage	$270K – $2.7M	+ Add to CRM
10 10x Group FHJBRWAE6 people	88🔒	München	DE	Seed–Late Stage	—	+ Add to CRM
CA CapMan	88🔒	Helsinki	FI	Series A–Late Stage	$2.2M – $64.8M	+ Add to CRM
GO Gore Range Capital ERHCCN3 people	88🔒	Southlake	US	Seed–Late Stage	$500K – $5M	+ Add to CRM
AX Axil Capital FSHGASJP7 people	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
BR Brace Pharma DERSTB3 people	88🔒	Atlanta	US	Late Stage	—	+ Add to CRM
H. H.I.G. BioHealth Partners SMTTBSDB6 people	88🔒	—		Growth–Late Stage	—	+ Add to CRM
BO Boston Millennia Partners BLECJLDC8 people	88🔒	Boston	US	Seed–Late Stage	$3M – $5M	+ Add to CRM
MU Muirwoods Ventures	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
RE Redhills Ventures LLC A"VCRE3 people · Leads rounds	88🔒	Las Vegas	US	Seed–Late Stage	$125K – $7M	+ Add to CRM
AL Alibaba Entrepreneurs Fund ALCC2 people	88🔒	Hong Kong	HK	Seed–Late Stage	$1.2M – $150M	+ Add to CRM
EM EMBL Ventures CL1 person	88🔒	Heidelberg	DE	Seed–Late Stage	$108K – $5.4M	+ Add to CRM
AG Agility Capital DCJCDSMN4 people	88🔒	Santa Barbara	US	Series C–Late Stage	$250K – $1.5M	+ Add to CRM
TA Target Partners BVMKWDSS7 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $3.2M	+ Add to CRM
TH The Finnish Innovation Fund Sitra IMMMTKST4 people	88🔒	Helsinki	FI	Seed–Late Stage	$108K	+ Add to CRM
AC ACORN BIOVENTURES GSAHML3 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM

PBM Capital

CharlottesvilleSeed–Late Stage

PBJRJPSG6 people

Percipient Capital

LondonSeed–Late Stage$1.3M – $6.3M

EFJGJB3 people

Waterman Ventures

UtrechtSeed–Late Stage

PRMKWV3 people

BioFrontier Partners, Inc.

TokyoSeries A–Late Stage$500K – $3M

YOHSMFHS11 people

Flying L Partners

Late Stage

WLACMLRL5 people

Med-Fine Capital

ShanghaiSeed–Late Stage

KUJZAYAL8 people

NewMargin Ventures

ShanghaiPre-Seed–Late Stage$425K – $200M

YHCTHHHK5 people

Origin Partners

HillsboroughSeed–Late Stage$3M – $5M

MYMEEJST5 people

Seido Capital

BrusselsPre-Seed–Late Stage$270K – $2.7M

CPOBTRPE4 people

10x Group

MünchenSeed–Late Stage

FHJBRWAE6 people

CapMan

HelsinkiSeries A–Late Stage$2.2M – $64.8M

Gore Range Capital

SouthlakeSeed–Late Stage$500K – $5M

ERHCCN3 people

Axil Capital

TokyoSeed–Late Stage

FSHGASJP7 people

Brace Pharma

AtlantaLate Stage

DERSTB3 people

H.I.G. BioHealth Partners

Growth–Late Stage

SMTTBSDB6 people

Boston Millennia Partners

BostonSeed–Late Stage$3M – $5M

BLECJLDC8 people

Muirwoods Ventures

SeoulSeed–Late Stage

Redhills Ventures LLC

Las VegasSeed–Late Stage$125K – $7M

A"VCRE3 people

Alibaba Entrepreneurs Fund

Hong KongSeed–Late Stage$1.2M – $150M

ALCC2 people

EMBL Ventures

HeidelbergSeed–Late Stage$108K – $5.4M

CL1 person

Agility Capital

Santa BarbaraSeries C–Late Stage$250K – $1.5M

DCJCDSMN4 people

Target Partners

MunichSeed–Late Stage$1.1M – $3.2M

BVMKWDSS7 people

The Finnish Innovation Fund Sitra

HelsinkiSeed–Late Stage$108K

IMMMTKST4 people

ACORN BIOVENTURES

New YorkSeed–Late Stage

GSAHML3 people

Data sourced from public filings and firms' own websites — see our methodology.